104 related articles for article (PubMed ID: 31957502)
21. DNA repair gene X-ray repair cross-complementing group 1 and xeroderma pigmentosum group D polymorphisms and risk of prostate cancer: a study from North India.
Mandal RK; Gangwar R; Mandhani A; Mittal RD
DNA Cell Biol; 2010 Apr; 29(4):183-90. PubMed ID: 20070155
[TBL] [Abstract][Full Text] [Related]
22. Impact of interaction between the G870A and EFEMP1 gene polymorphism on glioma risk in Chinese Han population.
Yang L; Qu B; Xia X; Kuang Y; Li J; Fan K; Guo H; Zheng H; Ma Y
Oncotarget; 2017 Jun; 8(23):37561-37567. PubMed ID: 28380465
[TBL] [Abstract][Full Text] [Related]
23. Associations between ERCC2 polymorphisms and gliomas.
Caggana M; Kilgallen J; Conroy JM; Wiencke JK; Kelsey KT; Miike R; Chen P; Wrensch MR
Cancer Epidemiol Biomarkers Prev; 2001 Apr; 10(4):355-60. PubMed ID: 11319176
[TBL] [Abstract][Full Text] [Related]
24. Combined effect of ERCC1 and ERCC2 polymorphisms on overall survival in non-squamous non-small-cell lung cancer patients treated with first-line pemetrexed/platinum.
Liao WY; Ho CC; Tsai TH; Chen KY; Shih JY; Yu CJ
Lung Cancer; 2018 Apr; 118():90-96. PubMed ID: 29572009
[TBL] [Abstract][Full Text] [Related]
25. Single nucleotide polymorphisms in DNA repair genes and the risk of laryngeal cancer: A meta-analysis.
Li F; Wang J; Chen M
Biomed Pharmacother; 2016 Mar; 78():92-100. PubMed ID: 26898429
[TBL] [Abstract][Full Text] [Related]
26. Variation in DNA repair genes ERCC2, XRCC1, and XRCC3 and risk of follicular lymphoma.
Smedby KE; Lindgren CM; Hjalgrim H; Humphreys K; Schöllkopf C; Chang ET; Roos G; Ryder LP; Falk KI; Palmgren J; Kere J; Melbye M; Glimelius B; Adami HO
Cancer Epidemiol Biomarkers Prev; 2006 Feb; 15(2):258-65. PubMed ID: 16492913
[TBL] [Abstract][Full Text] [Related]
27. Association of genetic polymorphisms in DNA repair pathway genes with non-small cell lung cancer risk.
Qian B; Zhang H; Zhang L; Zhou X; Yu H; Chen K
Lung Cancer; 2011 Aug; 73(2):138-46. PubMed ID: 21195504
[TBL] [Abstract][Full Text] [Related]
28. Association of EFEMP1 gene polymorphisms with the risk of glioma: A hospital-based case-control study in a Chinese Han population.
Zhang S; Ye Z; Song X; Chen G; Huai C; Wang Q; Song J; Lu D; Zhao Y; Chen H
J Neurol Sci; 2015 Feb; 349(1-2):54-9. PubMed ID: 25638659
[TBL] [Abstract][Full Text] [Related]
29. Association of BER and NER pathway polymorphism haplotypes and micronucleus frequencies with global DNA methylation in benzene-exposed workers of China: Effects of DNA repair genes polymorphisms on genetic damage.
Zhang GH; Ren JC; Luo M; Cui J; Du Y; Yang D; Cui S; Wang X; Wu W; Cao J; Xia ZL
Mutat Res Genet Toxicol Environ Mutagen; 2019 Mar; 839():13-20. PubMed ID: 30744808
[TBL] [Abstract][Full Text] [Related]
30. Association of Single Nucleotide Polymorphisms in XRCC1 (194) and XPD (751) with Age-related cataract.
Khosa T; Aslam S; Mustafa S; Akbar A; Shaikh RS; Iqbal F
Int Ophthalmol; 2018 Jun; 38(3):1135-1146. PubMed ID: 28560653
[TBL] [Abstract][Full Text] [Related]
31. Association of XPD (Lys751Gln) and XRCC1 (Arg280His) gene polymorphisms in myelodysplastic syndrome.
Joshi D; Korgaonkar S; Shanmukhaiah C; Vundinti BR
Ann Hematol; 2016 Jan; 95(1):79-85. PubMed ID: 26482462
[TBL] [Abstract][Full Text] [Related]
32. Polymorphisms in DNA Repair Gene and Susceptibility to Glioma: A Systematic Review and Meta-Analysis Based on 33 Studies with 15 SNPs in 9 Genes.
Liu K; Jiang Y
Cell Mol Neurobiol; 2017 Mar; 37(2):263-274. PubMed ID: 27055523
[TBL] [Abstract][Full Text] [Related]
33. DNA repair gene ERCC1 and XPD polymorphisms predict glioma susceptibility and prognosis.
Chen DQ; Yao DX; Zhao HY; Yang SJ
Asian Pac J Cancer Prev; 2012; 13(6):2791-4. PubMed ID: 22938460
[TBL] [Abstract][Full Text] [Related]
34. [Association of polymorphisms in glutathione-S-transferase and DNA repair genes with ovarian cancer risk in the Russian population].
Khokhrin DV; Khrunin AV; Moiseev AA; Gorbunov VA; Limborskaia SA
Genetika; 2012 Jul; 48(7):901-4. PubMed ID: 22988779
[TBL] [Abstract][Full Text] [Related]
35. XRCC3 and XPD/ERCC2 single nucleotide polymorphisms and the risk of cancer: a HuGE review.
Manuguerra M; Saletta F; Karagas MR; Berwick M; Veglia F; Vineis P; Matullo G
Am J Epidemiol; 2006 Aug; 164(4):297-302. PubMed ID: 16707649
[TBL] [Abstract][Full Text] [Related]
36. Associations between XRCC2 rs3218536 and ERCC2 rs13181 polymorphisms and ovarian cancer.
Zhang W; Zhang Z
Oncotarget; 2016 Dec; 7(52):86621-86629. PubMed ID: 27863412
[TBL] [Abstract][Full Text] [Related]
37. The genetic variations in DNA repair genes ERCC2 and XRCC1 were associated with the overall survival of advanced non-small-cell lung cancer patients.
Wang S; Wang J; Bai Y; Wang Q; Liu L; Zhang K; Hong X; Deng Q; Zhang X; He M; Wu T; Xu P; Guo H
Cancer Med; 2016 Sep; 5(9):2332-42. PubMed ID: 27465648
[TBL] [Abstract][Full Text] [Related]
38. Cisplatin ototoxicity in children: risk factors and its relationship with polymorphisms of DNA repair genes ERCC1, ERCC2, and XRCC1.
Turan C; Kantar M; Aktan Ç; Kosova B; Orman M; Bilgen C; Kirazlı T
Cancer Chemother Pharmacol; 2019 Dec; 84(6):1333-1338. PubMed ID: 31586226
[TBL] [Abstract][Full Text] [Related]
39. Association Studies of ERCC2 rs13181 Polymorphism with Pancreatic Cancer Susceptibility.
Shao T; Kou J
Crit Rev Eukaryot Gene Expr; 2021; 31(2):17-23. PubMed ID: 34347976
[TBL] [Abstract][Full Text] [Related]
40. Association between the ERCC2 Asp312Asn polymorphism and risk of cancer.
Xiao F; Pu J; Wen Q; Huang Q; Zhang Q; Huang B; Huang S; Lan A; Zhang Y; Li J; Zhao D; Shen J; Wu H; He Y; Li H; Yang X
Oncotarget; 2017 Jul; 8(29):48488-48506. PubMed ID: 28489582
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
